Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?

Stress

Volumn 15, Issue 3, 2012, Pages 243-261

  Tortosa Martinez J ^a   Clow, A ^b  

^a UNIVERSITY OF ALICANTE   (Spain)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Alzheimer; Cortisol; Hippocampus; HPA axis; Physical activity; Stress

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; HYDROCORTISONE; INSULIN; TAU PROTEIN;

AGING; ALCOHOL ABUSE; ALZHEIMER DISEASE; BRAIN ATROPHY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC STRESS; CIRCADIAN RHYTHM; COGNITION; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; HEAD INJURY; HEALTH BEHAVIOR; HIPPOCAMPUS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INSULIN SENSITIVITY; LIPID DIET; MEMORY; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NEUROFIBRILLARY TANGLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SOCIAL ASPECT; STRESS; TOBACCO DEPENDENCE;

ALZHEIMER DISEASE; COGNITION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOTOR ACTIVITY; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; RISK; RISK FACTORS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84859197446     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2011.629323     Document Type: Review

References (218)

1. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. 2004. Walking and dementia in physically capable elderly men. JAMA 292:1447-1453. (Pubitemid 39258337)
2. Adlard PA, Perreau VM, Pop V, Cotman CW. 2005. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25:4217-4221. (Pubitemid 40628765)
3. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 2006. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63:693-699.
4. Arkin SM. 2003. Student-led exercise sessions yield significant fitness gains for Alzheimer's patients. AmJ Alzheimers Dis Other Demen 18(3):159-170. (Pubitemid 36693300)
5. Arsenault-Lapierre G, Chertkow H, Lupien S. 2010. Seasonal effects on cortisol secretion in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 31: 1051-1054.
6. Arvanitakis Z, Wilson RS, Bienias JL, EvansDA, BennettDA. 2004. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666. (Pubitemid 38637681)
7. Barrientos R, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW, Maier SF. 2003. Brain-derived neurotrophic factor mRNA downregulation induced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121:847-853. (Pubitemid 37324583)
8. Berchtold NC, Chinn G, Chou M, Kesslak JP, Cotman CW. 2005. Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience 133:853-861. (Pubitemid 40798336)
9. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. 2006. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5:64-74. (Pubitemid 41790697)
10. Björntorp P. 1997. Obesity. Lancet 350: 423-426. (Pubitemid 27331604)
11. Blair SN, Connelly JC. 1996. How much physical activity should we do? The case for moderate amounts and intensities of physical activity. RQES 67:193-205. (Pubitemid 126421721)
12. Blumenthal JA, Babyak MA, Doraiswamy PM,Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A. 2007. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 69:587-596. (Pubitemid 47469807)
13. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR. 1999. Effects of exercise training on older patients with major depression. Arch Int Med 159:2349-2356. (Pubitemid 29501535)
14. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3:186-191. (Pubitemid 46825511)
15. Broocks A, Meyer T, Gleiter CH, Hillmer-Vogel U, George A, Bartmann U, Bandelow B. 2001. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects. Psychopharmacology 155:234-241. (Pubitemid 32477279)
16. Brown JD. 1991. Staying fit and staying well: Physical fitness as a moderator of life stress. J Pers Soc Psychol 60:555-561.
17. Cameron HA, Gould E. 1994. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 61:203-209. (Pubitemid 24219000)
18. Campbell JE, Rakhshani N, Fediuc S, Bruni S, Riddell MC. 2009. Voluntary wheel running initially increases adrenal sensitivity to adrenocorticotrophic hormone, which is attenuated with longterm training. J Appl Physiol 106(1):66-72.
19. Celsi F, Ferri A, Casciati A, D'Ambrosi N, Rotilio G, Costa A, Volonté C, Carrà MT. 2004. Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: Effect of estrogen and copper chelators. Neurochem Int 44: 25-33. (Pubitemid 37101140)
20. Chao H, Sakai RR, Ma LY, McEwen BS. 1998. Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 139:3112-3118. (Pubitemid 28512338)
21. Chrousos GP. 2009. Stress and disorders of the stress system. Nat Rev Endocrinol 5:374-381.
22. Cohen S, Wills TA. 1985. Stress, social support, and the buffering hypothesis. Psychol Bull 98(2):310-357.
23. Colcombe S, Kramer A. 2003. Fitness effects on the cognitive function of older adults: A meta-analytic study. Psychol Sci 14(2):125-130. (Pubitemid 37283096)
24. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. (Pubitemid 23275809)
25. Cotman CW, Berchtold NC. 2002. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295-301. (Pubitemid 34667010)
26. Cotman CW, Berchtold NC, Christie L-A. 2007. Exercise builds brain health: Key roles of growth factor cascades and inflammation. Trends Neurosci 30(9):464-472. (Pubitemid 47374831)
27. Cotman CW, Engesser-Cesar C. 2002. Exercise enhances and protects brain function. Exerc Sport Sci Rev 30:75-79. (Pubitemid 34298808)
28. Craft S. 2009. The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 66(3):300-305.
29. Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. 1996. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17:123-130. (Pubitemid 26019103)
30. Craft S, Watson GS. 2004. Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurol 3:169-178. (Pubitemid 38229951)
31. Craig R, Mindell J, Hirani V. 2008. Health survey for england-2008: Physical activity and fitness. Summary of key findings, The NHS Information Centre, available at: http://www.ic.nhs. uk/pubs/hse08physicalactivity
32. Csernansky JG, Dong H. 2006. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 163:2164-2169. (Pubitemid 46114238)
33. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. 1998. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51:2-17.
34. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. 2002. Depression: Perspectives from affective neuroscience. Annu Rev Psychol 53:545-574.
35. de Geus EJ, van Doornen LJ, Orlebeke JF. 1993. Regular exercise and aerobic fitness in relation to psychological make-up and physiological stress reactivity. Psychosom Med 55:347-363. (Pubitemid 23216231)
36. de Kloet ER, Joëls M, Holsboer F. 2005. Stress and the brain: From adaptation to disease. Nat Rev Neurosci 6:463-475. (Pubitemid 40769171)
37. De MoorMHM,Beem AL, Stubbe JH, Boomsma DI, De Geus EJC. 2006. Regular exercise, anxiety, depression and personality: A population-based study. Prev Med 42:273-279.
38. Dela F, Mikines KJ, Larsen JJ, Galbo H. 1999. Glucose clearance in aged trained skeletal muscle during maximal insulin with superimposed exercise. J Appl Physiol 87:2059-2067.
39. Department of Health. 2004. At least five a week: Evidence on the impact of physical activity and its relationship to health. A report from the chief medical officer. London.
40. Deuschle M, Gotthardt U, Schweiger U, Weber B, Kö rner A, Schmider J, Standhardt H, Lammers CH, Heuser I. 1997. With aging in humans the activity of the HPA system increases and its diurnal amplitude flattens. Life Sci 61:2239-2246. (Pubitemid 27521206)
41. Deuster PA, Chrousos GP, Luger A, DeBolt JE, Bernier LL, Trostmann UH, Kyle SB, Montgomery LC, Loriaux DL. 1989. Hormonal and metabolic responses of untrained, moderately trained, and highly trained men to three exercise intensities. Metabolism 38:141-148. (Pubitemid 19037679)
42. Deuster PA, Petrides JS, Singh A, Lucci EB, Chrousos GP, Gold PW. 1998. High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: Sexually dimorphic responses. J Clin Endocrinol Metab 83(9): 3332-3338. (Pubitemid 28500981)
43. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, Beckett LA, deToledo-Morrell L. 2001. MRIderived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 22:747-754. (Pubitemid 33055614)
44. Dickerson SS, Kemeny ME. 2004. Acute stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychological Bull 130:355-391. (Pubitemid 38614661)
45. Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, Gandevia SC, Gomez-Pinilla F, Greenwood BN, Hillman CH, Kramer AF, Levin BE, Moran TH, Russo-Neustadt AA, Salamone JD, Van Hoomissen JD,Wade CE, York DA, Zigmond MJ. 2006. Neurobiology of exercise. Obesity 14(3):345-356. (Pubitemid 46219751)
46. Dishman RK, Jackson EM, Nakamura Y. 2002. Influence of fitness and gender on blood pressure responses during active or passive stress. Psychophysiology 39:568-576. (Pubitemid 35006903)
47. Dishman RK, Renner KJ, White-Welkley JE, Bunnell BN. 2000. Treadmill exercise training augments brain norepinephrine response to familiar and novel stress. Brain Res Bull 52: 337-342. (Pubitemid 30462203)
48. Dong H, Yuede CM, Yoo HS, Martin MV, Deal C, Mace AG, Csernansky JG. 2008. Corticosterone and related receptor expression are associated with increased b-amyloid plaques in isolated Tg2576 mice. Neuroscience 155:154-163.
49. Droste SK, Chandramohan Y, Hill LE, Linthorst AC, Reul JMHM. 2007. Voluntary exercise impacts on the rat hypothalamicpituitary-adrenocortical axis mainly at the adrenal level. Neuroendocrinology 86:26-37. (Pubitemid 47206897)
50. Droste SK, Collins A, Lightman SL, Linthorst AC, Reul JM. 2009. Distinct, time-dependent effects of voluntary exercise on circadian and ultradian rhythms and stress responses of free corticosterone in the rat hippocampus. Endocrinology 150(9): 4170-4179.
51. Droste SK, Gesing A, Ulbricht S, Mü ller MB, Linthorst AC, Reul JM. 2003. Effects of long-term voluntary exercise on the mouse hypothalamic- pituitary-adrenocortical axis. Endocrinology 144(7):3012-3023. (Pubitemid 36819903)
52. Droste SK, Schweizer MC, Ulbricht S, Reul JMHM. 2006. Longterm voluntary exercise and the mouse hypothalamic-pituitaryadrenocortical axis: Impact of concurrent treatment with the antidepressant drug tianeptine. J Neuroendocrinol 18:915-925. (Pubitemid 44660625)
53. Duman RS. 2005. Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism. Neurobiol Aging 26: 88-93.
54. Duman RS, Monteggia LM. 2006. A neurotrophic model for stressrelated mood disorders. Biol Psychiatry 59:1116-1127.
55. Elliot MSJ, Ballard CG, Kalaria RN, Perry R, Hortobágyi T, Francis PT. 2009. Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain 132:1858-1865.
56. Fediuc S, Campbell JE, Riddell MC. 2006. Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats. J Appl Physiol 100:1867-1875. (Pubitemid 43845861)
57. Fleshner M, Campisi J, Deak T, Greenwood BN, Kintzel JA, Leem TH, Smith TP, Sorensen B. 2002. Acute stressor exposure facilitates innate immunity more in physically active than in sedentary rats. Am J Physiol Regul Integr Comp Physiol 282: 1680-1686.
58. Fox NC,Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN. 1996. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119:2001-2007.
59. Fratiglioni L, Paillard-Borg S, Winblad B. 2004. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3:343-353. (Pubitemid 38648855)
60. Garza AA, Ha TG, Garcia C, Chen MJ, Russo-Neustadt AA. 2004. Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav 77: 209-220. (Pubitemid 38125152)
61. Gella A, Durani N. 2009. Oxidative stress in Alzheimer disease. Cell Adh Migr 3(1):88-93.
62. Goekint M, De Pauw K, Roelands B, Njemini R, Bautmans I, Mets T, Meeusen R. 2010. Strength training does not influence serum brain-derived neurotrophic factor. Eur J Appl Physiol 110:285-293.
63. Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, TsuiW, Richardson S, Javier E, Convit A. 2007. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50:711-719. (Pubitemid 46355836)
64. Goto C, Higashi Y, Kimura M, Noma K, Hara K, Nakagawa K, Kawamura M, Chayama K, Yoshizumi M, Nara I. 2003. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: Role of endothelium-dependent nitric oxide and oxidative stress. Circulation 108:530-535. (Pubitemid 36961165)
65. Gould E. 1999. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21:46-51.
66. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. 2006. Glucocorticoids increase amyloid-b and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26: 9047-9056. (Pubitemid 44319396)
67. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer Ll. 2003. Depression as a risk factor for Alzheimer disease: The MIRAGE study. Arch Neurol 60: 753-759. (Pubitemid 36569895)
68. Greenwood BN, Foleyac TE, Day HEW, Burhans D, Brooks L, Campeau S, Fleshner M. 2005. Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol Psychiatry 57(5): 559-568. (Pubitemid 40311992)
69. Greenwood BN, Strong PV, Dorey AA, Fleshner M. 2007. Therapeutic effects of exercise: Wheel running reverses stressinduced interference with shuttle box escape. Behav Neurosci 121(5):992-1000. (Pubitemid 350051301)
70. Gruenewald TL, Seeman TE. 2010. Stress and aging: A biological double jeopardy? Annu Rev Gerontol Geriatr 30:155-177.
71. Grune T, Reinheckel T, Davies KJA. 1997. Degradation of oxidized proteins in mammalian cells. FASEB J 11:526-534. (Pubitemid 27274426)
72. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. 2003. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163:1524-1528. (Pubitemid 36835095)
73. Gustaw-Rothenberg K. 2009. Dietary patterns associated with Alzheimer's disease: Population based study. Int J Environ Res Public Health 6:1335-1340.
74. Haan MN, Wallace R. 2004. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 25:1-24. (Pubitemid 38543608)
75. Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ. 1995. Hypothalamic-pituitaryadrenal system function in patients with Alzheimer's disease. Neurobiol Aging 16(2):205-220.
76. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ, Owen N. 2008. Objectively measured sedentary time, physical activity, and metabolic risk the Australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care 31(2):369-371. (Pubitemid 351213354)
77. Heiden M, Lyskov E, Nakata M, Sahlin K, Sahlin T, Barnekow-Bergkvist M. 2007. Evaluation of cognitive behavioural training and physical activity for patients with stress-related illnesses: A randomized controlled study. J Rehabil Med 39(5):366-373.
78. Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y. 2009. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 66(3):343-348.
79. Heyn P, Abreu BC, Ottenbacher KJ. 2004. The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis. Arch Phys Med Rehabil 85: 1694-1704. (Pubitemid 39349417)
80. Hill LE, Droste SK, Nutt DJ, Linthorst ACE, Reul JMHM. 2010. Voluntary exercise alters GABAA receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain. J Psychopharmacol 24:745-756.
81. Holmes DS, McGilley BM. 1987. Influence of a brief aerobic training program on heart rate and subjective response to a psychologic stressor. Psychosom Med 49(4):366-374. (Pubitemid 17138568)
82. Ice GH, Katz-Stein A, Himes J, Kane RL. 2004. Diurnal cycles of salivary cortisol in older adults. Psychoneuroendocrinology 29:355-370. (Pubitemid 37487953)
83. Iqbal K, Grundke-Iqbal I. 2010. Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement 6: 420-424.
84. Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA. 2003. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75(1):81-88. (Pubitemid 36577583)
85. Ivy JL, Zderic TW, Fogt DL. 1999. Prevention and treatment of non-insulin-dependent diabetes mellitus. Exerc Sport Sci Rev 27:1-35.
86. Jackson EM, Dishman RK. 2006. Cardiorespiratory fitness and laboratory stress: A meta-regression analysis. Psychophysiology 43:57-72.
87. Jacobson L, Sapolsky R. 1991. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Rev 12:118-134.
88. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. 2004. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474-481. (Pubitemid 38174565)
89. Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS, Lee SH, Emson PC, Suh YH. 2006. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV7171-CT100 transgenic mice, an Alzheimer's disease model. FASEB J 20:729-731. (Pubitemid 46671196)
90. Ji LL. 1999. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med 222:283-292.
91. Kannangara TS, Lucero MJ, Gil-Mohapel J, Drapala RJ, Simpson JM, Christie BR, van Praag H. 2011. Running reduces stress and enhances cell genesis in aged mice. Neurobiol Aging 32(12): 2279-2286.
92. Karlamangla AS, Singer BH, Greendale GA, Seeman TE. 2005. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Psychoneuroendocrinology 30:453-460. (Pubitemid 40249811)
93. Karp A, Paillard-Borg S, Wang HX, Silverstein M, Winblad B, Fratiglioni L. 2006. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 21:65-67.
94. Kasapis C, Thompson PD. 2005. The effects of physical activity on serum creactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 45:1563-1569. (Pubitemid 40704486)
95. Kiive E,Maaroos J, Shlik J, Tõ ru I, Harro J. 2004. Growth hormone, cortisol and prolactin responses to physical exercise: Higher prolactin response in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 28:1007-1013. (Pubitemid 39223356)
96. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. 2005. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62:1556-1560. (Pubitemid 41434560)
97. Kjær M. 1992. Regulation of hormonal and metabolic responses during exercise in humans. Exerc Sport Sci Rev 20:161-184.
98. Korkushko OV, Frolkis MV, Shatilo VB. 1995. Reaction of pituitary-adrenal and autonomic nervous systems to stress in trained and untrained elderly people. J Auton Nerv Syst 54: 27-32.
99. Kovács P, Juránek I, Stankovićová T, Sevec P. 1996. Lipid peroxidation during acute stress. Pharmazie 51:51-53. (Pubitemid 26053708)
100. Kramer AF, Erickson KI. 2007. Capitalizing on cortical plasticity: Influence of physical activity on cognition and brain function. Trends Cogn Sci 11:342-348. (Pubitemid 47077916)
101. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. 2004. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: Impact of age and gender. Psychoneuroendocrinology 29:83-98. (Pubitemid 37303960)
102. Kudielka BM, HellhammerD,Wü st S. 2009. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology 34:2-18.
103. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Schurmeyer T, Kirschbaum C. 2000. Psychosocial stress and HPA functioning: No evidence for a reduced resilience in healthy elderly men. Stress 3:229-240. (Pubitemid 30423181)
104. Kumari M, Badrick E, Sacker A, Kirschbaum C, Marmot M, Chandola T. 2010. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology 35:1091-1099.
105. Kyrou I, Tsigos C. 2009. Stress hormones: Physiological stress and regulation of metabolism. Curr Opin Pharmacol 9:787-793.
106. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W. 2006. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144:73-81. (Pubitemid 46768225)
107. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. 2001. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58(3):498-504. (Pubitemid 32217469)
108. LeeKW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK, Han PL. 2009. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J Neurochem 108:165-175.
109. Lopez JF, Chalmers DT, Little KY, Watson SJ. 1998. Regulation of serotonin1A, glucorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol Psychiatry 43:547-573. (Pubitemid 28198224)
110. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP. 1987. Acute hypothalamic-pituitary-adrenal response to the stress of treadmill exercise. N Engl J Med 316:1309-1315.
111. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ. 1998. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci 1:69-73. (Pubitemid 128652645)
112. Lupien SJ, Lepage M. 2001. Stress, memory, and the hippocampus: Can't live with it, can't live without it. Behav Brain Res 127: 137-158. (Pubitemid 33062407)
113. Lupien SJ, Nair NP, Brière S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ. 1999. Increased cortisol levels and impaired cognition in human aging: Implication for depression and dementia in later life. Rev Neurosci 10(2):117-139. (Pubitemid 29392579)
114. Maher P, Schubert DR. 2009. Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 9(5):617-630.
115. McEwen BS. 1994. The plasticity of the hippocampus is the reason for its vulnerability. Semin Neurosci 6:239-246. (Pubitemid 24310598)
116. McEwen BS. 1998. Protective and damaging effects of stress mediators. New Engl J Med 338:171-179.
117. McEwen BS. 2008. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583:174-185.
118. Meerlo P, Sgoifo A, Turek FW. 2002. The effects of social defeat and other stressors on the expression of circadian rhythms. Stress 5:15-22. (Pubitemid 34241890)
119. Messier C. 2003. Diabetes, Alzheimer's disease and apolipoprotein genotype. Exp Gerontol 8:941-946. (Pubitemid 37040796)
120. Miller TP, Taylor J, Rogerson S, Mauricio M, Kennedy Q, Schatzberg A, Tinklenberg J, Yesavage J. 1998. Cognitive and noncognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone. Int Psychogeriatr 10: 85-96. (Pubitemid 28284562)
121. Moosavi M, Naghdi N, Maghsoudi N, Zahedi Asl S. 2007. Insulin protects against stress-induced impairments in water maze performance. Behav Brain Res 176:230-236. (Pubitemid 44880084)
122. Mooy JM, de Vries H, Grootenhuis PA, Bouter LM, Heine RJ. 2000. Major stressful life events in relation to prevalence of undetected type 2 diabetes: The Hoorn study. Diabetes Care 23:197-201. (Pubitemid 30071024)
123. Mora S, Cook N, Buring JE, Ridker PM, Lee I-M. 2007. Physical activity and reduced risk of cardiovascular events: Potential mediating mechanisms. Circulation 116:2110-2118. (Pubitemid 350060348)
124. Moraska A, Deak T, Spencer RL, Roth D, Fleshner M. 2000. Treadmill running produces both positive and negative physiological adaptations in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 279:1321-1329.
125. Moraska A, Fleshner M. 2001. Voluntary physical activity prevents stress induced behavioral depression and anti-KLH antibody suppression. Am J Physiol Regul Integr Comp Physiol 281: 484-489.
126. Mori TA, Dunstan DW, Burke V, Croft KD, Rivera JH, Beilin LJ, Puddey IB. 1999. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 48:1402-1408. (Pubitemid 29536439)
127. Moyna NM, Bodnar JD, Goldberg HR, Shurin MS, Robertson RJ, Rabin BS. 1999. Relation between aerobic fitness level and stress induced alterations in neuroendocrine and immune function. Int J Sports Med 20:136-141. (Pubitemid 29112674)
128. Mueller PJ. 2007. Exercise training and sympathetic nervous system activity: Evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol 34:377-384.
129. Nader N, Chrousos GP, Kino T. 2010. Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 21(5):277-286.
130. Näsman B, Olsson T, Viitanen M, Carlstrom K. 1995. A subtle disturbance in the feedback regulation of the hypothalamicpituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology 20:211-220. (Pubitemid 24366201)
131. Nichol KE, Deeny SP, Seif J, Camaclang K, Cotman CW. 2009. Exercise improves cognition and hippocampal plasticity in APOE 34 mice. Alzheimers Dement 5:287-294.
132. Nieman DC, Henson DA, Austin MD, Brown VA. 2005. Immune response to a 30-minute walk. Med Sci Sports Exerc 37(1): 57-62. (Pubitemid 40076017)
133. Nojima H,Watanabe H. 2008. Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus. Metabolism 57:170-176.
134. Nuntagij P, Oddo S, LaFerla FM, Kotchabhakdi N, Ottersen OP, Torp R. 2009. Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: An electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canines. J Alzheimers Dis 16:315-323.
135. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, DeKosky ST. 2003. Vascular cognitive impairment. Lancet Neurol 2:89-98. (Pubitemid 37443329)
136. Ogonovsky H, Berkes I, Kumagai S, Kaneko T, Tahara S, Goto S, Radák Z. 2005. The effects of moderate-, strenuous-and overtraining on oxidative stress markers, DNA repair and memory, in rat brain. Neurochem Int 46:635-640. (Pubitemid 40614866)
137. Onor ML, Trevisol M, Negro C, Signorini A, Saina M, Aguglia E. 2007. Impact of a multimodal rehabilitative intervention on demented patients and their caregivers. Am J Alzheimers Dis Other Demen 22:261-272. (Pubitemid 47330146)
138. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. 1999. Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 53:1937-1942.
139. Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC. 2005. A meta-analysis of cortisol response to challenge in human aging: Importance of gender. Psychoneuroendocrinology 30: 80-91. (Pubitemid 39195047)
140. Pajović SB, Pejić S, Stojiljković V, Gavrilović L, Dronjak S, Kanazir DT. 2006. Alterations in hippocampal antioxidant enzyme activities and sympatho-adrenomedullary system of rats in response to different stress models. Physiol Res 55:453-460. (Pubitemid 44291103)
141. Palleschi L, Vetta F, De Gennaro E, Idone G, Sottosanti G, Gianni W, Marigliano V. 1996. Effect of aerobic training on the cognitive performance of elderly patients with senile dementia of Alzheimer type. Arch Gerontol Geriatr 5:47-50.
142. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW. 2007. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 28(12):1821-1833. (Pubitemid 47539700)
143. Parachikova A, Cotman CW. 2007. Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 28:143-153. (Pubitemid 47615454)
144. Parachikova A, Nichol KE, Cotman CW. 2008. Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis 30:121-129.
145. Park E, Chan O, Li Q, Kiraly M, Matthews SG, Vranic M, Riddell MC. 2005. Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated. Am J Physiol Regul Integr Comp Physiol 289(5):1360-1371.
146. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlà T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D. 2010. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288:112-116.
147. Podewils LJ, Guallar E, et al. 2005. Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study. Am J Epidemiol 161:639-651. (Pubitemid 40411092)
148. Querfurth HW, LaFerla FM. 2010. Mechanisms of disease. Alzheimer's disease. N Engl J Med 362:329-344.
149. Radak Z, Chung HY, Goto S. 2005. Exercise and hormesis: Oxidative stress-related adaptation for successful aging. Biogerontology 6:71-75. (Pubitemid 41583294)
150. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S. 2008. Exercise, oxidative stress and hormesis. Ageing Res Rev 7:34-42.
151. Radak Z, Taylor AW, Ohno H, Goto S. 2001. Adaptation to exercise-induced oxidative stress: From muscle to brain. Exerc Immunol Rev 7:90-107. (Pubitemid 32911044)
152. Reagan LP. 2007. Insulin signaling effects on memory and mood. Curr Opin Pharmacol 7:633-637. (Pubitemid 350177560)
153. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. 2003. The Associations Between Physical Activity and Inflammatory Markers in High-Functioning Older Persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 51(8): 1125-1130. (Pubitemid 36993471)
154. Rimmele U, Zellweger BC, Marti B, Seiler R, Mohiyeddini C, Ehlert U, Heinrichs M. 2007. Trained men show lower cortisol, heart rate and psychological responses to psychosocial stress compared with untrained men. Psychoneuroendocrinology 32: 627-635. (Pubitemid 47017584)
155. Rimmele U, Seiler R, Marti B, Wirtz PH, Ehlert U, Heinrichs M. 2009. The level of physical activity affects adrenal and cardiovascular reactivity to psychosocial stress. Psychoneuroendocrinology 34(2):190-198.
156. Rimmer JH, Smith DL. 2009. Alzheimer's disease. In: Durstine JL, Moore GE, Painter PL, Roberts SD, editors. ACSM's management for persons with chronic diseases and disabilities. Champaign, IL: Human Kinetics. p 368-374.
157. Risacher SL, Saykin AJ,West JD, Shen L, Firpi HA, McDonald BC. 2009. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6: 347-361.
158. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Rivière D, Vellas B. 2007. Exercise program for nursing home residents with Alzheimer's disease: A 1-year randomized, controlled trial. J Am Geriatr Soc 55:158-165. (Pubitemid 46184389)
159. Rosmond R, Dallman MF, Bjö rntorp P. 1998. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859. (Pubitemid 28496305)
160. Rothermundt M, Arolt V. 2001. Inflammatory markers in major depression and melancholia. J Affect Disord 63:93-102. (Pubitemid 32200503)
161. Rothman SM, Mattson MP. 2010. Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med 12(1): 56-70.
162. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. 2005. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4(11):690-691.
163. Rovio S, Spulber G, Nieminen LJ, Niskanen E, Winblad B, Tuomilehto J, Nissinen A, Kivipelto M. 2010. The effect of midlife physical activity on structural brain changes in the elderly. Neurobiol Aging 31:927-936.
164. Russo-Neustadt A, Beard RC, Cotman CW. 1999. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21: 679-682. (Pubitemid 29486636)
165. Salmon P. 2001. Effects of physical exercise on anxiety, depression, and sensitivity to stress: A unifying theory. Clin Psychol Rev 21: 33-61.
166. Sapolsky RM, Krey LC, McEwen BS. 1984. Glucocorticoidsensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Nat Acad Sci 81: 6174-6177. (Pubitemid 15220802)
167. Sato H, Takahashi T, Sumitani K, Takatsu H, Urano S. 2010. Glucocorticoid generates ROS to induce oxidative injury in the hippocampus, leading to impairment of cognitive function of rats. J Clin Biochem Nutr 47:224-232.
168. Schaaf M, de Jong J, de Kloet ER, Vreugdenhil E. 1998. Downregulation of BDNF mRNA and protein in the rat hippocamppus by corticosterone. Brain Res 813:112-120. (Pubitemid 29012524)
169. Seeman TE, McEwen BS, Singer BK, Albert MS, Rowe JW. 1997. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab 82(8):2458-2465. (Pubitemid 27337857)
170. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483. (Pubitemid 34441738)
171. Shimomura T, Anan F, Masaki T, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H, Kobayashi H. 2011. Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients. Eur J Clin Invest 41:751-758.
172. Simons LA, Simons J, McCallum J, Friedlander Y. 2006. Lifestyle factors and risk of dementia: Dubbo study of the elderly. MJA 184:68-70. (Pubitemid 43174197)
173. Sinyor D, Schwartz SG, Peronnet F, Brisson G, Seraganian P. 1983. Aerobic fitness level and reactivity to psychosocial stress: Physiological, biochemical, and subjective measures. Psychosom Med 45(3):205-217. (Pubitemid 13058350)
174. Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Santamato A, Ranieri M, Fiore P, Capurso A, Panza F. 2008. Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother 8:133-158.
175. Strachan MWJ, Reynolds RM, Frier BM, Mitchell RJ, Price JF. 2008. The relationship between type 2 diabetes and dementia. Br Med Bull 88:131-146.
176. Swanwick GRJ, Kirby M, Bruce I, Buggy F, Coen RF, Coakley D, Lawlor BA. 1998. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: Lack of association between longitudinal and cross-sectional findings. Am J Psychiatry 155: 286-289. (Pubitemid 28074297)
177. Taaffe DR, Irie F, Masaki KH, Abbott RD, Petrovitch H, Ross GW, White LR. 2008. Physical activity, physical function, and incident dementia in elderly men: The Honolulu-Asia aging study. J Gerontol A Biol Sci Med Sci 63(5):529-535.
178. Takeda S, Naoyuki S, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, ShinoharaM, Rakugi H, Morishita R. 2010. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Ab deposition in an Alzheimer mouse model with diabetes. PNAS 107(15):7036-7041.
179. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB. 2003. Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial. JAMA 290(15):2015-2022. (Pubitemid 37430584)
180. Thomas DE, Elliott EJ, Naughton GA. 2006. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 3:1-41.
181. Timofeeva E, Huang Q, Richard D. 2003. Effects of treadmill running on brain activation and the corticotropin-releasing hormone system. Neuroendocrinology 77:388-405. (Pubitemid 36831203)
182. Traustadó ttir T, Bosch PR, Cantu T, Matt KS. 2004. Hypothalamic-pituitary-adrenal axis response and recovery from high-intensity exercise in women: Effects of aging and fitness. J Clin Endocrinol Metab 89(7):3248-3254. (Pubitemid 38951889)
183. Traustadó ttir T, Bosch PR, Matt KS. 2005. The HPA axis response to stress in women: Effects of aging and fitness. Psychoneuroendocrinology 30:392-402. (Pubitemid 40188194)
184. Trejo J, Cairo E, Torres-Aleman I. 2001. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21:1628-1634. (Pubitemid 32182203)
185. Uhart M, Chong RY, Oswald L, Lin P-I, Wand GS. 2006. Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity. Psychoneuroendocrinology 31:642-652.
186. Unger JB, Johnson CA, Marks G. 1997. Functional decline in the elderly: Evidence for direct and stress-buffering protective effects of social interactions and physical activity. Ann Behav Med 19(2):152-160.
187. Vaidya V, Marek GJ, Aghajanian GA, Duman RS. 1997. 5-HT2A receptormediated regulation of BDNF mRNA in the hippocampus and the neocortex. J Neurosci 17:2785-2795. (Pubitemid 27155012)
188. van Cauter E, Leproult R, Kupfer D. 1996. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468-2473. (Pubitemid 26240262)
189. van Praag H, Christie BR, Sejnowski TJ, Gage FH. 1999. Running enhances neurogenesis, learning and long-term potentiation in mice. Proc Natl Acad Sci USA 96:13427-13431.
190. van Praag H, Shubert T, Zhao C, Gage FH. 2005. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 25:8680-8685. (Pubitemid 41362045)
191. Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. 2006. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res 1070:124-130. (Pubitemid 43247751)
192. Viru A, Karelson K, Smirnova K. 1992. Stability and variability in hormonal responses to prolonged exercise. Int J Sports Med 13(3):230-235.
193. Wahbeh H, Kishiyama S, Zajdel D, Oken B. 2008. Salivary cortisol awakening response in mild Alzheimer disease, caregivers, and noncaregivers. Alzheimer Dis Assoc Disord 22(2):181-183.
194. Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z, Zhao B. 2011. b-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Rad Biol Med 50:122-129.
195. Wang X, ZhengW, Xie JW,Wang T,Wang SL, Teng WP,Wang ZY. 2010. Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener 5:305-310.
196. Warner-Schmidt JL, Duman RS. 2006. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 16(3):239-249.
197. Watanabe T, Morimoto A, Sakata Y, Wada M, Murakami N. 1991. The effect of chronic exercise on the pituitary-adrenocortical responses in conscious rats. J Physiol 439:691-699.
198. Watson K, Fan GH. 2005. Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67:757-765. (Pubitemid 40365323)
199. Weiner MF, Vobach S, Olsson K, Svetlik D, Risser RC. 1997. Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry 42:1030-1038. (Pubitemid 27496434)
200. Weiner MF, Vobach S, Svetlik D, Risser RC. 1993. Cortisol secretion and Alzheimer's disease progression: A preliminary report. Biol Psychiatry 34:158-161. (Pubitemid 23257742)
201. Weuve J, Kang JH, Manson JE, Breteler MM,Ware JH, Grodstein F. 2004. Physical activity, including walking, and cognitive function in older women. JAMA 292:1454-1461. (Pubitemid 39258338)
202. White-Welkley JE, Bunnell BN, Mougey EH, Meyerhoff JL, Dishman RK. 1995. Treadmill exercise training and estradiol differentially modulate hypothalamic-pituitary-adrenal cortical responses to acute running and immobilization. Physiol Behav 57(3):533-540.
203. White-Welkley J, Warren G, Bunnell BN, Mougey EH, Meyerhoff JL, Dishman RK. 1996. Treadmill exercise training and estradiol increase plasma ACTH and prolactin after novel footshock. J Appl Physiol 80(3):931-939. (Pubitemid 26087261)
204. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. 2005. Midlife cardiovascular risk factors and risk of dementia in late-life. Neurology 64:277-281.
205. Williams CL, Tappen RM. 2007. Effect of exercise on mood in nursing home residents with Alzheimer's disease. Am J Alzheimers Dis Other Demen 22:389-397. (Pubitemid 351168895)
206. Wilson MM, Greer SE, Greer MA, Roberts L. 1980. Hippocampal inhibition of pituitary-adrenocortical function in female rats. Brain Res 197:433-441. (Pubitemid 10040304)
207. Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, BennettDA. 2006. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 27:143-153. (Pubitemid 44651434)
208. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. 2007. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 69:1911-1920. (Pubitemid 350100349)
209. Wolf OT. 2009. Stress and memory in humans: Twelve years of progress? Brain Res 1293:142-154.
210. Wolf OT, Convit A, de Leon MJ, Caraos C, Qadri SF. 2002a. Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: Relationship to magnetic resonance imaging derived hippocampus and cingulate gyrus volumes. Neuroendocrinology 75:241-249. (Pubitemid 34455097)
211. Wolf OT, Convit A, Thorn E, de Leon MJ. 2002b. Salivary cortisol day profiles in elderly with mild cognitive impairment. Psychoneuroendocrinology 27:777-789. (Pubitemid 35340806)
212. World Health Organisation. 2010. Global recommendations on physical activity and health, 65 years and above, available at http://www.who.int/ dietphysicalactivity/physical-activity-recommendations-65years.pdf
213. Wrighten SA, Piroli GG, Grillo CA, Reagan LP. 2009. A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta 1792:444-453.
214. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T. 2003. Inflammatory markers and cognition in wellfunctioning African-American and white elders. Neurology 61:76-80. (Pubitemid 36818750)
215. Zafir A, Banu N. 2009. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 12(2):167-177.
216. Zaidi SMKR, Banu N. 2004. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin Chim Acta 340:229-233. (Pubitemid 38167528)
217. Zheng H, Liu Y, LiW, Yang B, Chen D, Wang X, Jiang Z,Wang H, Wang Z, Cornelisson G, Halberg F. 2006. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav Brain Res 168:47-55. (Pubitemid 43152052)
218. Zhuo J-M, Wang H, Praticò D. 2011. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32(9):562-571.